These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 7905955)
1. Risk of endometrial cancer after tamoxifen treatment of breast cancer. van Leeuwen FE; Benraadt J; Coebergh JW; Kiemeney LA; Gimbrère CH; Otter R; Schouten LJ; Damhuis RA; Bontenbal M; Diepenhorst FW Lancet; 1994 Feb; 343(8895):448-52. PubMed ID: 7905955 [TBL] [Abstract][Full Text] [Related]
2. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892 [TBL] [Abstract][Full Text] [Related]
3. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567 [TBL] [Abstract][Full Text] [Related]
4. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496 [TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381 [TBL] [Abstract][Full Text] [Related]
6. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. Fornander T; Hellström AC; Moberger B J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Swerdlow AJ; Jones ME; J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574 [TBL] [Abstract][Full Text] [Related]
8. Tamoxifen therapy for breast cancer and endometrial cancer risk. Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593 [TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy. Sasco AJ; Chaplain G; Amoros E; Saez S Epidemiology; 1996 Jan; 7(1):9-13. PubMed ID: 8664408 [TBL] [Abstract][Full Text] [Related]
10. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen. Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers. Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123 [TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536 [TBL] [Abstract][Full Text] [Related]
13. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma. Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291 [TBL] [Abstract][Full Text] [Related]
14. Risk for endometrial cancer following breast cancer: a prospective study in Sweden. Adami HO; Bergström R; Weiderpass E; Persson I; Barlow L; McLaughlin JK Cancer Causes Control; 1997 Nov; 8(6):821-7. PubMed ID: 9427424 [TBL] [Abstract][Full Text] [Related]
15. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases]. Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860 [TBL] [Abstract][Full Text] [Related]
17. Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study. Althuis MD; Sexton M; Langenberg P; Bush TL; Tkaczuk K; Magaziner J; Khoo L Cancer; 2000 Aug; 89(4):800-10. PubMed ID: 10951343 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study. Pukkala E; Kyyrönen P; Sankila R; Holli K Int J Cancer; 2002 Jul; 100(3):337-41. PubMed ID: 12115550 [TBL] [Abstract][Full Text] [Related]
19. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E; Libera H; Kimmig R; Forsting M Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840 [TBL] [Abstract][Full Text] [Related]
20. Endometrial carcinoma in a tamoxifen-treated breast cancer patient. Jose R; Kekre AN; George SS; Seshadri L Aust N Z J Obstet Gynaecol; 1995 May; 35(2):201. PubMed ID: 7677690 [No Abstract] [Full Text] [Related] [Next] [New Search]